Pharming Group NV banner

Pharming Group NV
XBER:PHGN

Watchlist Manager
Pharming Group NV Logo
Pharming Group NV
XBER:PHGN
Watchlist
Price: 1.426 EUR
Market Cap: €960.3m

Wall St Price Targets

PHGN Price Targets Summary
Pharming Group NV

Wall Street analysts forecast PHGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PHGN is 2.969 EUR with a low forecast of 2.392 EUR and a high forecast of 3.591 EUR.

Lowest Forecast
Price Target
2.392 EUR
68% Upside
Average Forecast
Price Target
2.969 EUR
108% Upside
Highest Forecast
Price Target
3.591 EUR
152% Upside
Pharming Group NV Competitors:
Price Targets
NWSA
News Corp
32% Upside
AMSF
Amerisafe Inc
24% Upside
CSGP
CoStar Group Inc
53% Upside

Revenue
Forecast

41% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
41% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 5 years is 20%.

Operating Income
Forecast

N/A
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss
N/A
Past Growth
36% / Year
Estimated Growth
Estimates Accuracy
-16%
Average Miss

The compound annual growth rate for Operating Income over the next 5 years is 36%.

Net Income
Forecast

N/A
Past Growth
130% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss
N/A
Past Growth
130% / Year
Estimated Growth
Estimates Accuracy
-24%
Average Miss

The compound annual growth rate for Net Income over the next 4 years is 130%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is PHGN's stock price target?
Price Target
2.969 EUR

According to Wall Street analysts, the average 1-year price target for PHGN is 2.969 EUR with a low forecast of 2.392 EUR and a high forecast of 3.591 EUR.

What is the Revenue forecast for Pharming Group NV?
Projected CAGR
20%

Over the last 14 years, the compound annual growth rate for Revenue has been 41%. The projected CAGR for the next 5 years is 20%.

What is the Operating Income forecast for Pharming Group NV?
Projected CAGR
36%

The compound annual growth rate for Operating Income over the next 5 years is 36%.

What is the Net Income forecast for Pharming Group NV?
Projected CAGR
130%

The compound annual growth rate for Net Income over the next 4 years is 130%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett